The Global Cannabis Stock Index Jets Higher in January – New Cannabis Ventures

From the deeply depressed year-end 2022 close of 9.71, the Global Cannabis Stock Index rose 10.1% in January to 10.69.

The index fell 23.7% in Q3 and 13.8% in Q4, ending 2022 down 70.4%:

Since the peak in February 2021, the Global Cannabis Stock Index has dropped 88.4% from the 92.48 closing high:

The strongest 4 names in January all rose by more than 31%:

All of these stocks fell tremendously in 2022. There was no news driving the rebounds.

The 4 weakest names in January all declined by more than 11%:

Village Farms was hammered after an equity offering. Columbia Care has moved to a massive discount to the deal price implied by its pending merger with Cresco Labs. Innovative Industrial Properties moved to a new multi-year low after providing a Q4 update. Trulieve has been weak with many other multi-state operators and has neared its low set in March of 2021.

We will summarize the index performance again in a month. You can learn more about the index members and the qualifications for inclusion by visiting the Global Cannabis Stock Index. Be sure to bookmark the page to stay current on cannabis stock price movements within the day or from day-to-day.

New Cannabis Ventures maintains seven proprietary indices designed to help investors monitor the publicly-traded cannabis stocks, including the Global Cannabis Stock Index as well as the Canadian Cannabis LP Index and its three sub-indices. The sixth index, the American Cannabis Operator Index, was launched at the end of October 2018 and tracks the leading cultivators, processors and retailers of cannabis in the United States. More recently, we introduced the Ancillary Cannabis Index at the end of March 2021, reflecting the increasing number of publicly-traded companies providing goods or services to cannabis operators.

Get ahead of the crowd by signing up for 420 Investor when it becomes available again. It’s the largest & most comprehensive premium service for cannabis investors since 2013.

Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter

$33.9 million in illegal cannabis found in Oakland raids – SFGATE

Authorities seized over 30,000 marijuana plants, 2,720 pounds of marijuana and multiple firearms at an illegal cannabis-growing operation in Oakland last week, according to the Department of Cannabis Control (DCC). The agency estimated that the illegal cannabis was worth over $33.9 million.

The two-day raid took place on Jan. 26 and 27 and was conducted at two warehouses on separate sides of the city. Lt. Miguel Félix Ibarra, with the Oakland Police Department, said the agency coordinated with the DCC on the “high-risk search warrants” at both facilities.

“This search warrant operation was part of a large-scale marijuana cultivation and tax evasion investigation,” Ibarra told SFGATE in an email. “Two large warehouses located on these properties had been converted into sophisticated marijuana cultivation facilities.”

It’s not clear how many individuals were involved in the allegedly illegal cannabis-growing operation. Neither agency said if anyone was arrested or if charges were filed. The DCC said it also seized one handgun and one “AR style rifle” during a Thursday raid of a suspect’s residence. The two raids took place in West Oakland, at 1685 34th St., and in East Oakland, at 1217 48th Ave.


Illegal cannabis farms have remained in the East Bay even after the state legalized adult-use cannabis in 2016. On Jan. 10, authorities seized over $3 million in cannabis at a Livermore warehouse. And in 2021, authorities dismantled what they called the largest illegal cannabis-growing operation in Bay Area history, with $42 million worth of plants and millions of dollars in cash seized in San Leandro.

The DCC estimated that the marijuana plants seized last week were worth $27.9 million and the processed marijuana flower was worth $5.9 million. That estimate works out to roughly $823 per plant and $1,650 per pound of cannabis flower, which is significantly higher than the current market rate for legal cannabis in California. Furthermore, cannabis sold outside the state in illicit markets can be worth more than legal marijuana sold in California’s legal market.

Authorities found illegal cannabis at this Oakland warehouse, at 1685 34th St.

Authorities found illegal cannabis at this Oakland warehouse, at 1685 34th St.

screen shot via Google Maps

The DCC did not explain how it estimated the totals.

File photo of marijuana plants.

File photo of marijuana plants.


FDA takes a pass on CBD rules. Here’s why Northern California’s … – North Bay Business Journal

A recent federal decision to not regulate CBD in food has the cannabis industry up in arms because it allows an unregulated part of the business to thrive without oversight.

The U.S. Food and Drug Administration has said that if any regulation is needed, Congress should manage it.

FDA Deputy Commissioner Janet Woodcock went on to say in a Jan. 26 statement that CBD “raises various safety concerns, especially with long-term use.” Before reaching this conclusion, the federal agency created a working group to explore CBD as a food additive, which is already being manufactured in beverages and other products without regulation.

CBD (cannabidiols), the non-psychoactive compound compared to THC, is used for a variety of ailments such as joint pain. But the compound, derived from hemp or cannabis, is unregulated. In 2018, passage of the U.S. Farm Bill made hemp legal. But if the hemp plant contains more than 0.3% THC, which creates the “high” when consuming it, then it’s considered marijuana. And that’s illegal.

For years, Congress has failed to pass measures to change that, leading to the largely unregulated CBD-added market, with it showing up in various products from topicals to energy drinks.

California Assemblywoman Cecilia Aguiar-Curry, D-Davis, said the federal “indecision” about CBD has led her to consider sponsoring a bill that would legalize hemp-derived CBD as a food additive.

“I’m frustrated our state has to do what the federal government can’t do,” she told the Business Journal. “The interest is there. This could be a billion-dollar industry.”

She said that without regulation, the market is open to introduction of products laced with compounds not fully derived from the hemp plant.

Tiffany Devitt, government relations chief at a Sonoma County producer, CannaCraft, agrees that the line needs to be drawn between marketing pure CBD and chemically-laced products because it creates a stigma for the legal industry.

Devitt, who also serves on the California Cannabis Industry Association board, contends the FDA backing off from placing CBD under its wing says it’s “not capable of regulating CBD,” surmising the agency either lacks the will or the ability as a pharmaceutical-centric watchdog organization. Turning away from the task may negatively “create a gray zone.”

“What’s weird is the FDA seems to be grossly exaggerating the risk of CBD,” said Devitt, whose Santa Rosa company has developed a CBD-infused beverage called Hi-Fi Hops in partnership with Petaluma-based Lagunitas brewery.

Devitt cited studies such as the 2010 World Health Organization’s that deems CBD as being safe and effective in treating certain health conditions.

Although the FDA failed to act on determining whether CBD is safe and effective in food, the federal government is still interested in policing how it’s marketed. The mere threat of the federal government policing the food additive may prompt legal, organic producers to look over their shoulders, Devitt insists.

According to Lauren Mendelsohn, a cannabis-specialist attorney with the Sebastopol-based law firm, Omar Figueroa, the FDA does conduct occasional inspections of how CBD is marketed and packaged.

“It’s being policed to a certain extent. I’ve heard of warning letters going out to some (producers),” she said, pointing out the agency has declined to take on the bigger issue of fully regulating the marketing and distribution of the product.

“(The FDA’s indecision) felt like kind of a slap in the face,” she said.

The decision by the FDA comes at a time when polling suggests a majority of the American public is getting more comfortable with the idea of cannabis-related products.

A November 2022 Gallup survey revealed 68% of Americans support making cannabis legal for adults nationwide.

Thus far, 37 states have legalized at least its medical use — 21 of them for recreational purposes.

“Today’s announcement by the FDA underscores the urgent need for Congress and the Administration to take swift action to modernize federal cannabis policy and regulate CBD and other products appropriately and in harmony with the vast majority of states that have already legalized cannabis in some form,” National Cannabis Industry Association CEO and Co-founder Aaron Smith said in a statement following the Jan. 26 decision.

But other groups applaud the FDA’s decision as a health matter based on what some contend the public still doesn’t know about the substance.

“I’m happy to see the FDA take a position and express concern about CBD products. This is an important step forward in terms of safety,” said Jim Keddy, executive director of Youth Forward, a Sacramento-based group that is critical of what it contends is how the cannabis industry markets to kids.

Keddy agrees with “some concerns” from the legitimate CBD industry, but he argues more research is necessary.

But the arguments give all the more credence to the FDA needing to step in to distinguish between what’s safe and what’s not, some proponents say.

“Yes, consumers should care in theory that the FDA supports the guarantee that foods and supplements are safe,” said Martin Lee, director of Project CBD in Healdsburg, which advocates the safe use of CBD. “Congress already opened the door for this when they wrote the Farm Bill. We’re not against regulation. What we need is good regulation because many businesses use the regulatory vacuum to take advantage and mislabel (their products). We have no way of knowing what we’re getting.”

Susan Wood covers law, cannabis, production, tech, energy, transportation, agriculture as well as banking and finance. For 27 years, Susan has worked for a variety of publications including the North County Times, Tahoe Daily Tribune and Lake Tahoe News. Reach Wood at 530-545-8662 or

Get 50% Off Sitewide At Upgrade, The Number One Cannabinoid … –

Warning: sprintf(): Too few arguments in /home/prosofte/domains/ on line 319

Looking to try hemp-derived cannabinoids from a trusted retailer with over a decade of experience in the cannabis industry? Upgrade has you covered. 

For years, the brand would produce premium goods for other companies to sell. Finally, they’ve stepped into the spotlight to help consumers better understand what they’re using, who it’s from, and how it can benefit them. 

Upgrade is deeply passionate about creating industry-leading formulations to ensure everyone can reap the reward of various cannabinoid blends tailored toward specific experiences. Do you want to chill? Or maybe you’re looking for a product that enhances focus. 

Upgrade provides premium edibles and vaporizers containing the newest and most effective cannabinoids to help you feel good. Browse cannabinoids like THC-P, THC-V, HHC, HHC-P, and much more, all at affordable prices. 

When used together, these cannabinoids produce a phenomenon known as the ensemble effect or entourage effect, which amplifies their effects for a more complete and well-rounded experience. 

Lucky for you, Upgrade wants to help you experience this natural phenomenon at half the price. See below for more best-selling products at Upgrade, which you can snag for 50% off. 

Arizer: Vaporizer Pioneers Delivering High-Quality Devices –

Based in Kitchener, Ontario, this Canadian vaporizer company has been in business long before the plant was legal. Having launched in 2005, Arizer continues to set new standards for vaporizer technology, quality, and performance.

The brand has spent the last 18 years extensively researching and designing new ways we can consume cannabis in the safest, cleanest, and most flavorful way possible. The brand is celebrated worldwide for providing customers with cutting-edge devices at affordable prices, and their helpful customer service remains unmatched.

Arizer offers an impressive lineup of vaporizers, each bringing something different to the table. For maximum portability, check out their ArGo Vaporizer, a quality dry herb vape designed for connoisseurs on the go. It’s a discreet device that fits in the palm of your hand, featuring patented hybrid heating technology for smooth, cloudy draws.

Want a device that stays at home? Look to Arizer’s V-Tower, an economical and efficient desktop vaporizer for dry herbs and aromatherapy. The pure convection heating with a fast-heating ceramic element delivers the utmost flavorful and aromatic vapor, and the Glass Cyclone Bowl lets you control your dose effortlessly.

See below for more information about Arizer’s top-of-the-line, celebrated Air MAX.

Weed Weviews: Some THC Stuff I Sampled in January – Racket – Racket

Welcome to Weed Weviews, a verbal foible that’s become the very real name of this monthly column.

This summer, I made my way through a ton of THC products—all in the name of journalism, of course. But there’s still so much stuff out there I want to try, so I thought it’s be fun to keep the party going. Each month, I’m going to highlight a few things I dabbled in, be it beverages, gummies, chocolates, candies, oils, or… “other” (weed comes in a lot of different forms these days!). Think of it like our Doin’ Beers column, but for weed.

As I’ve explained a few times before, I am a casual but experienced weed traveler who’s familiar and comfortable with the effects of THC, whether I’m just feeling a whisper of the sweet bud or a full-on hurricane. 

Also important: These are just my experiences. As we all know, time and place can impact reactions. So can mindset, experience levels, overall sensitivity to chemicals, and energy level. Everyone’s body and brain is different. So stay safe and be careful out there, folks. 

All right! Let’s get this party started.

Credit: Jessica Armbruster

Stigma THC Gummies, Rapid Intake

About: Stigma is a Minneapolis-based THC and CBD company. They’ve got oils, they’ve got CBD doggie treats, they’ve got drinks, and even CBD cream. Right now people can shop their products online, but before the pandemic they also had a shop in the North Loop. They’re planning to reopen in a new location (but the same neighborhood) in the coming months. 

Flavor: Of all the gummies I’ve tried, these are way bigger and softer, which is is great for people who like to play around with dosage, as they’re easy to halve or even quarter. While I enjoyed both flavors, I found myself chewing on a few unmixed gelatine clumps a few times. 

Blast-off time: About 30 minutes, which is about average for a gummy. You do hit the higher side of the high faster though. So if you’re the kind of person who takes a dose, then takes another dose 30 minutes later because you’re not high enough, these might be good for you.

Experience: I definitely felt chill and ready for bed. If you’re in the mood for a warm blanket and a cute movie on the couch, these are a good time.

Stoneover? Nope!

Credit: Jessica Armbruster

Retro Bakery Infused Sugar

About: These guys make super-tasty chocolates, Oreo-style cookies, and Nutty Buddy-esque crunchy bars. I’ve already done some experimenting with this straight-up sugar product, but I wanted to try to incorporate these things in a few baking project, since simply adding this sugar to tea is convenient, but not as exciting as unleashing my inner stoner Betty Crocker on my friends.

Flavor: I bought an oatmeal sandwich kit from the $1 basket Lund’s sometimes has in the middle of their frozen food aisle. I decided to add the sugar to the icing I made for the filling.

Blast-off time: Less than 30. 

Experience: Have you ever overused butter when making weed brownies? And then you and your friends didn’t want to waste them but they’re too rich and they’re making your stomach hurt? I did that, but with sugar. I’m going to blame the recipe, not the product. Cooking with weed is kinda tricky, and I failed. The sugar high eclipsed any weed energy I was hoping to derive from the snack.

Stoneover? No. Just shame.

Credit: Jessica Armbruster

Cultivated CBD Plus

About: This Minnesota company sells a ton of CBD stuff as well as Delta-9 gummies. According to their site, their gummies come from a traditional French recipe that is referred to as “Pâte de Fruit.” Ooh la la!

Flavor: These taste like Gatorade. I’m not saying that these aren’t classy French-style gummies, but blue-raspberry is just never going to come off as complex or natural.

Blast-off time: Probably closer to 45 minutes with these.

Experience: The blast off takes a tiny bit more time, but these are great. These aren’t going to bed gummies, so give yourself a project or at least some time to wind down before you try to sleep.

Also, I gotta send love to the container. So many THC edibles these days come in a child protective Ziplock seal-type thing, which I also find to be “Jessica-proof.” This brand’s canister design, with little plastic nubs you squeeze to pop the top open kinda remind me of the mechanism used on some orange prescription drug bottles, and they keep dumb babies outta of my stash. (FYI: There are no babies in my social circle.)

Stoneover? Nope! Woke up refreshed the next morning.

Credit: Jessica Armbruster

Take Five THC Tea Lemonade

About: Surly Brewing is getting in on the drinkable weed market by teaming up with Stigma Cannabis Co., whose gummies I enjoyed this month as well. The collab includes two bubbly THC bevvies, Lime and Mixed Berry, and the brand-new Tea Lemonade.  

Flavor: Okay, I love Arnie Palmers, especially in the summertime. The tea tastes instant, as is to be expected with canned tea. The lemonade has hints of Country Time, which is serviceable too. So yeah, I would say this is pretty dang drinkable, but it’s nothing fancy. I would expect to find a similar concoction (minus the THC) in the cooler section of a gas station or CVS. Every time I crack one of these and take the first sip I get the same rush to the brain that I get when I drink an Arizona Green Tea.

Blast-off time: About 10 minutes? But I gotta say, each time I tried this I barely felt the effects. Liquid THC tends to make me feel a little slower, but not necessarily stoned. Maybe these would be nice for people who are looking for a body focused high?

Experience: I suspect that with drinks like these I need to layer the consumption and drink more than one. But honestly, I don’t think I could drink multiple cans of this since it’s so sweet and the cans are generous-sized. I think, for me, the best way to enjoy this would be to pop a gummy and then drink this at a leisurely pace–a nice approach if you’re a beer person who needs a little drinking action with your THC. 

Stoneover? Nada. 

Booker Laments 'Cannabis Crisis’ Of Prohibition, Laying Out Marijuana Banking Challenges In New Congress – Marijuana Moment

Sen. Cory Booker (D-NJ) says that ongoing marijuana banking issues under prohibition amount to a “cannabis crisis,” and while he thinks there’s still a shot to enact reform with Republicans in control of the House, he’s underscoring the challenges of the new political dynamic on Capitol Hill.

Advocates and stakeholders remain frustrated that Congress was unable to pass a marijuana banking bill and other modest reforms last session when Democrats held majorities in both chambers. But eyes are now turned to what’s achievable in the 118th Congress.

Booker told that it’s his “intention to try to drive it as far as we can go, but the dynamics have shifted pretty dramatically” with the House flip. He said enacting reform is “definitely going to be harder, but not impossible.”

“I do think there’s a chance. Remember there’s always been a good bipartisan coalition of people that want to do something,” the senator said. “The urgencies that pushed us towards some kind of partnership are still there, on the business side as well as the restorative justice side.”

Booker has faced particular criticism from certain stakeholders over how his position on banking legislation has evolved, with the senator at one point vowing to block any efforts to advance a standalone Secure and Fair Enforcement (SAFE) Banking Act without equity components but eventually expressing interest in compromise to get something done.

He remains committed to incorporating equity into legislation he plans to work on this session, but the task is steeper without Democratic control of the House.

The senator said in an earlier interview following last year’s election that he believed it could take “many years from now” to pass cannabis legislation if Democrats didn’t get the job done during the lame duck session.

Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.

Senate Majority Leader Chuck Schumer (D-NY), who led negotiations over the so-called SAFE Plus package, has faulted Republicans for keeping the proposal out of key legislation that he’d hoped to attach it to last session.

Rep. Patrick McHenry (R-NC), who now serves as chairman of the House Financial Services Committee, said last month that while he still opposes the banking proposal, he wouldn’t stand in its way.

The White House was asked last week where President Joe Biden stands on marijuana banking reform, and Press Secretary Karine Jean-Pierre said that the ball is in Congress’s court, with no current plans for administrative action to resolve the issue.

Biden hasn’t provided a clear policy position on marijuana banking, though he’s said that states should be able to decide their own cannabis laws without federal interference. His administration has also become more vocal marijuana reform since the president issued a mass cannabis possession pardon in October.

Colorado Governor Names Psychedelic Advisory Board Members, Including Top Researcher And Former Cannabis Journalist

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

D.C. Mayor Signs Major Medical Marijuana Expansion Bill, Eliminating Licensing Caps, Providing Tax Relief And More – Marijuana Moment

The mayor of Washington, D.C. has signed a bill to make fundamental changes to the medical marijuana program in the nation’s capital. That will involve eliminating cannabis business licensing caps, providing tax relief to operators, further promoting social equity and creating new regulated business categories such as on-site consumption facilities and cannabis cooking classes.

It will also provide a pathway for current “gifting” operators that sell non-cannabis items in exchange for “free” marijuana products to enter the licensed market, while empowering officials to crack down on those who continue to operate illegally.

The D.C. Council passed the legislation from Chairman Phil Mendelson (D) last month, and Mayor Muriel Bowser (D) signed it into law on Monday.

The Medical Cannabis Amendment Act further codifies that adults can self-certify as medical marijuana patients. That reform is all the more critical since congressional lawmakers passed an appropriations package that maintains a controversial rider blocking the District from implementing a system of regulated, adult-use cannabis commerce, despite the House and Senate having excluded it in their earlier versions.

In spite of that rider, D.C. lawmakers refiled a bill last week to legalize marijuana sales. A federal oversight agency determined last year that the congressional rider does not preclude local officials from taking procedural steps to prepare for the eventual reform, such as holding hearings.

With respect to the newly enacted medical cannabis expansion, while the as-introduced version of the legislation proposed a higher cap on dispensaries than is allowed under current law, it was revised and no longer includes a cap—though it does create a process for regulators to set caps or moratoriums “on the issuance of cultivation center, retailer or internet retailer licenses.”

Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.

Another amendment that was adopted prior to passage concerns enforcement actions that regulators will be authorized to take against unlicensed marijuana operators, including those that have leveraged the District’s “gifting” policy to circumvent regulations.

The timeline for when enforcement action can be taken has shifted back and forth as the bill has moved through Council committees, with the original version requiring regulators to wait 180 days, the last version significantly narrowing the window to 30 days and the now-enacted legislation saying enforcement action can’t be taken for at least 315 days after the bill’s enactment.

The application period for unlicensed businesses to seek a license was extended from 60 to 90 days, and unlicensed businesses can also now apply to for cultivation center licenses. The bill was additionally amended to create a process for applicants to appeal license rejections.

Notably, the legislation also contains language that says marijuana businesses can deduct taxes under local statute that they’re prohibited from making under the federal Internal Revenue Services (IRS) code known as 280E.

The law as signed makes permanent a temporary self-certification policy that’s been in effect, allowing adults 21 and older to become medical cannabis patients who can buy marijuana from dispensaries without receiving a doctor’s recommendation. Under the current short-term law that the mayor signed last year, medical marijuana patient registrations have continued to surge—with the program adding about 1,500 more patients in September alone.

The legislation aims to promote social equity in the industry by prioritizing business licenses for people who’ve been disproportionately impacted by the drug war. But the relevant provisions have been similarly revised throughout its legislative journey.

Initially, the measure stipulated that 50 percent of certain licenses needed to be set aside for equity applicants and existing medical cannabis operators in perpetuity. The previously amended version required 100 percent to be set aside for those groups for a certain number of years, depending on the license type.

Now as approved by the full Council and signed into law, it’s gone back to the 50 percent requirement, with “all new retailer, internet retailer, courier, cultivation center, and manufacturer” licenses being reserved for social equity applicants. Regulators must make applications available for new licensees no later than May 1, 2023.

Existing medical cannabis cultivation centers and dispensaries will be permitted to be vertically integrated under one provision of Mendelson’s amendment.

The proposal further calls for the creation of a new license category for internet retailers that would be able to sell marijuana without having a physical storefront.

The legislation also renames the key regulatory agency from the Alcoholic Beverage Regulation Administration (ABRA) to Alcoholic Beverage and Cannabis Administration (ABC).

While many advocates have welcomed the legislative efforts to expand cannabis access in the District, they’ve also continued to push for an end to the federal blockade that’s prevented D.C. from establishing a regulated market, despite voters approving an initiative to legalize possession and personal cultivation in 2014.

But that effort failed for the 2023 Fiscal Year, with congressional lawmakers passing a final spending deal before the new session that keeps the rider, even though both the House and Senate had omitted it in their respective versions last year.

After President Joe Biden issued a proclamation in October pardoning Americans who’ve committed federal marijuana possession offenses, as well as people who’ve violated the law in D.C., U.S. Rep. Eleanor Holmes Norton (D-DC) called on the president to go further by federally legalizing cannabis and letting the District establish a commercial cannabis market and grant clemency on its own.

The congresswoman said the ongoing local ban, which was maintained in Biden’s first two budget proposals, represents a “shocking violation of D.C. home rule by a Democratic administration.”

A coalition of local, state and national advocacy organizations recently asked the U.S. attorney general to formally adopt a policy of non-enforcement to allow the District to legalize marijuana sales even in light of the ongoing congressional ban.

A poll released in September found that D.C. voters strongly support marijuana legalization and oppose a crackdown on the cannabis “gifting” market that’s emerged in the absence of regulated sales.

Bowser, Norton and other elected officials in the city have routinely criticized Congress for singling out the District and depriving it of the ability to do what a growing number of states have done without federal interference.

Norton told Marijuana Moment in a phone interview in July that she was “fairly optimistic” that the rider would not be included in the final spending package. She added that the D.C. self-certification policy is an “effective workaround” until then.

Meanwhile, the mayor signed a bill in July that bans most workplaces from firing or otherwise punishing employees for marijuana use.

The reform is designed to build upon on a previous measure lawmakers approved to protect local government employees against workplace discrimination due to their use of medical cannabis.

Also, late last month, D.C. lawmakers sent another bill to the mayor that the mayor allowed to be enacted without her signature that contains an amendment to automatically expunge marijuana possession records for offenses that took place before the District enacted a limited cannabis legalization law in 2014.

Tens Of Thousands Of Truckers Are Testing Positive For Marijuana And Leaving The Industry Amid Labor Shortage, Federal Data Shows

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

XVAPE Offers Best-In-Class Vaporizers At Affordable Prices –

As mentioned, XVAPE has an impressive lineup of vaporizers for dry herbs, concentrates, and both. This time around, we’ll focus on XVAPE’s renowned XLUX ROFFU, a dry herb vaporizer that brings out the true intended flavors, aromas, and effects of your herb. 

This state-of-the-art vaporizer was meticulously designed to provide consumers with a superior dry herb vaping experience through precision engineering and convection heating. This cutting-edge heating technology provides almost instant heat-up time, resulting in thick, dense, and potent clouds that bring cannabis consumption to a whole new level. 

The XLUX ROFFU brings you the best in vaporizers at an affordable price. Not to mention the added USB-C feature for fast charging and a swappable battery. If you happen to lose power, don’t fret. Simply swap out the small, pocketable, and portable battery for another, and get back to puffing. 

This modern vaporizer features the following:

  • Contemporary convection technology
  • Zirconia jewelry-grade cooling spiral
  • Durable, functional, and stylish body
  • Magnetic ceramic top
  • Quick heat-up time
  • Waste-reducing technology
  • Dual usage modes (Session and On-Demand)
  • Vibrant 0.96 illumi-display
  • Haptic feedback
  • Replaceable 18650 Battery with USB-C Charger

The XLUX ROFFU could be the last vaporizer you’ll ever need. For more devices, products, and information about XVAPE, visit their website at